PDS Biotechnology (PDSB) Prices 6M Share Common Offering at $2.75/Sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LRCX
6. LVS
7. SAP
8. CSX
9. SPY
10. KNX

Go back to PDS Biotechnology (PDSB) Prices 6M Share Common Offering at $2.75/Sh

PDS Biotechnology (PDSB) Tops Q2 EPS by 4c

August 13, 2020 6:02 AM EDT

PDS Biotechnology (NASDAQ: PDSB) reported Q2 EPS of ($0.19), $0.04 better than the analyst estimate of ($0.23).

Second Quarter 2020 and Recent Business Highlights

Announced publication of PDS0101 triple combination preclinical study by the National Cancer Institute;Initiated Phase 2 clinical trial of PDS0101 triple combination, led by the National Cancer Institute, for the treatment of advanced human papillomavirus (HPV)-associated cancers;Announced Phase 2 trial to evaluate PDS0101 in combination with standard of care for treatment of locally advanced cervical cancer at The University of Texas MD Anderson Cancer Center;Launched novel PDS Biotech-owned vaccine... More

PDS Biotechnology (PDSB) Announces Proposed Public Offering of Common Stock

August 10, 2020 4:38 PM EDT

PDS Biotechnology Corporation (PDS Biotech or the Company) (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Companys proprietary Versamune® T-cell activating technology, today announced that it intends to offer and sell shares of its common stock in an... More